MRNA vs TDC · rev $145.0M vs P/E 7.3, rev $854.0M
Moderna Inc (MRNA) versus Teradata Corp (TDC) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Teradata Corp (TDC) is a software - infrastructure company listed on NYSE.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported TDC revenue for 2026-06-30 was $854.0M. Net income was $381.0M. Revenue was up 92.3% from 2026-03-31 to 2026-06-30. TDC currently screens at market cap $2.99B and trailing P/E 7.3.
MRNA currently screens at market cap $24.52B. TDC currently screens at market cap $2.99B and trailing P/E 7.3.
Not investment advice. Open the MRNA and TDC stock pages for the full models.
Not investment advice.